Moody Aldrich Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,059
Closed -$418K 211
2024
Q1
$418K Sell
6,059
-2,418
-29% -$153K 0.07% 157
2023
Q4
$627K Buy
8,477
+2,996
+55% +$196K 0.11% 127
2023
Q3
$374K Buy
+5,481
New +$465K 0.07% 148
2021
Q2
Sell
-2,138
Closed -$282K 179
2021
Q1
$282K Buy
2,138
+340
+19% +$46.5K 0.04% 162
2020
Q4
$238K Buy
+1,798
New +$217K 0.04% 164
2017
Q4
Sell
-10,010
Closed -$472K 92
2017
Q3
$472K Sell
10,010
-7,445
-43% -$300K 0.49% 78
2017
Q2
$617K Sell
17,455
-3,005
-15% -$92.8K 0.77% 61
2017
Q1
$483K Buy
+20,460
New +$405K 0.83% 63

Other funds holding EXAS

Moody Aldrich Partners's EXAS Position: Q2 2024 in Review

Moody Aldrich Partners sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 6,059 shares — an estimated $418K sold.

Moody Aldrich Partners first reported a position in EXAS in Q1 2017 and held it in 8 quarters. The position peaked at $627K in Q4 2023. 544 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Moody Aldrich Partners reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Moody Aldrich Partners sold 6,059 Exact Sciences shares in Q2 2024, an estimated $418K.
  • Moody Aldrich Partners first reported a position in Exact Sciences in Q1 2017 and held it in 8 quarters.
  • Moody Aldrich Partners's Exact Sciences position peaked at $627K in Q4 2023.
  • 544 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Moody Aldrich Partners's 13F filing for Q2 2024, filed 24 Jul 2024.